PGR and colorectal carcinoma: Collectively, our data and the earlier studies suggest that E2 and/or P4 could provide alternative therapeutic approaches against CRC and their efficacy could be dependent on the expression profiles of ERs and PGR in malignant colonic tissues (31, 57, 59, 60).